Research has found that IRE1 α/KIRA8, an inhibitor of the XBP1 signalling pathway, can significantly inhibit tumour growth and has a better therapeutic effect when combined with PD‐1 antibodies.25 This evidence concerns the gene ERN1 and neoplasm.